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Antibiotics have been a mainstay for treatment of bacterial infec-
tions since their discovery. However, the continued misuse and over-
use of antibiotics has led to the rapid development and spread of 
antibiotic-resistant strains of bacteria. As a result, antibiotic resis-
tance is rising more rapidly than new antibiotics are being developed. 
This threatens to end the golden age of antibiotics we are currently 
living in and begin the postantibiotic era (Perry, Waglechner, & 
Wright, 2016). One such bacterial pathogen that has become a prob-
lem in the clinical setting due to the wide variety of antibiotics it has 
developed resistances to is Staphylococcus aureus.
Staphylococcus aureus is a Gram-positive cocci bacterium 
that can be found as a commensal on human skin and nares. 
Approximately 30% of the population live asymptomatically col-
onized with S. aureus. However, it can also act as a pathogenic 
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Abstract
Antibiotic-resistant strains of bacteria such as methicillin-resistant Staphylococcus 
aureus are a threat to human health, and effective treatment options against them 
are needed. This study aimed to determine whether the insecticide permethrin was 
capable of inhibiting the growth of S. aureus or if some other component of a perme-
thrin cream was responsible for a decrease in scabies associated bacterial infection 
previously observed. Ten S. aureus strains were grown in the presence of permethrin 
and formaldehyde both alone and in combination with percent inhibition determined 
by viable counts. Also, a time-kill assay was conducted on S. aureus exposed to the 
same conditions. Finally, the morphology of S. aureus grown in the presence of per-
methrin was examined by scanning electron microscopy. Bacterial inhibition by per-
methrin ranged from 0% to 41% whereas inhibition by formaldehyde was 100%. The 
time-kill curves of permethrin exposed cells were very similar to the positive growth 
control while the formaldehyde and combination exposure showed complete inhibi-
tion even at the 0-hr time point. The scanning electron micrographs of permethrin 
grown S. aureus showed healthy cocci cells with no sign of cell damage. Our results 
show that permethrin is not capable of inhibiting the growth of bacteria enough for 
it to be termed bactericidal. Formaldehyde is a known antiseptic and therefore was 
responsible for the antibacterial effect observed after the use of permethrin cream.
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bacterium in humans causing diseases that range from minor 
skin infections to more serious infections such as impetigo, os-
teomyelitis, and endocarditis (Rojo, Barrios, Palacios, Gomez, & 
Chaves, 2010). Infections with S. aureus are typically treated with 
antibiotics but the spread of increasingly resistant strains of S. au-
reus has made treatment with antibiotics difficult. One of the most 
widespread antibiotic-resistant strains of S. aureus is methicil-
lin-resistant S. aureus (MRSA) that is resistant to β-lactam antibiot-
ics including penicillin and methicillin. As many as 60% of clinically 
isolated strains of S. aureus are resistant to methicillin (Romaniuk 
& Cegelski, 2015).
Even antibiotics like vancomycin and daptomycin, which were 
considered last-resort antibiotics for MRSA infections, have become 
ineffective against certain strains of S. aureus (Bayer, Schneider, & 
Sahl, 2013; McGuinness, Malachowa, & DeLeo, 2017; Walters et al., 
2015). As resistances continue to develop, alternative treatment op-
tions are required. This includes the development of new antibiotics 
as well as novel treatment methods such as anti-virulence medication 
and	phage	therapy	(Khodaverdian	et	al.,	2013;	Zhang	et	al.,	2018).
Infections with S. aureus are often associated with scabies 
infections. Scabies is an infectious skin disease caused by the 
Sarcoptes scabiei mite and is spread primarily by skin-to-skin con-
tact. The mites infect a host and burrow into the skin causing itch-
ing and irritation which can disrupt the skin barrier. Skin barrier 
disruption allows for the development of secondary bacterial in-
fections, typically of Group A Streptococci or S. aureus and can lead 
to diseases such as impetigo and endocarditis (May et al., 2016). 
Permethrin is a synthetic pyrethroid and the preferred treatment 
for scabies infections. Permethrin's mode of action against sca-
bies mites involves binding to the mite's voltage-gated sodium 
channels in a hydrophobic pocket formed by the helices of two 
separate protein domains (Field, Davies, O'Reilly, Williamson, & 
Wallace, 2017). This binding prevents the transition from an ac-
tivated state to an inactivated state allowing an influx of sodium 
ions, causing prolonged depolarization, paralysis, and death of the 
mite (Andriantsoanirina et al., 2014).
Impetigo is a skin infection commonly found in children that, as 
mentioned above, can accompany scabies infections. It is usually 
caused by S. aureus but can also be caused by Streptococcus pyogenes 
and presents on the skin as blisters or ulcers (Ghazvini, Treadwell, 
Woodberry, Nerette, & Powery, 2017). Impetigo contributes to a high 
burden of disease (especially in resource-poor communities) with an 
estimated global burden of 162 million children in low to low-middle 
income countries being affected by impetigo. In Australia alone, it is 
estimated that over 15,000 indigenous children suffer from impe-
tigo at any one time (Bowen et al., 2015). Impetigo is usually treated 
with topical antibiotic creams but in more serious infections an oral 
antibiotic may be administered instead. The first-choice creams for 
the treatment of impetigo are fusidic acid and mupirocin but resis-
tances to even these antibiotics have led to the use of retapamulin as 
an alternative treatment option (Alsterholm, Flytström, Bergbrant, 
& Faergemann, 2010; Pereira, 2014; Poovelikunnel, Gethin, & 
Humphreys, 2015).
A prior study by Whitehall, Kuzulugil, Sheldrick, and Wood (2013) 
assessed the health burden associated with scabies and pyoderma in 
children at Mt Isa Hospital. This study also identified the bacteria 
present in the infected patients (Group A streptococcus, S. aureus and 
Group C streptococcus). The treatment methods included soap baths, 
administration of the antibiotic flucloxacillin, application of a 5% 
permethrin cream, and an adequate diet with iron supplementation. 
This treatment regimen was sufficient in curing both scabies and as-
sociated bacterial infections. However, subsequent analysis of the 
bacterial strains found that most of the staphylococci strains were 
resistant to flucloxacillin. This was despite all the patients recovering 
and implicates either the soap and water baths or the 5% permethrin 
cream as having a major benefit for treating antibiotic-resistant bac-
terial infections.
This study aimed to identify the cause of the observed antibac-
terial effect in Whitehall et al. (2013). In doing so, a new antibac-
terial treatment method could be identified for use in combating 
antibiotic-resistant strains of bacteria. The effect of permethrin 
on insects is well characterized but there are no reports of it pos-
sessing antibacterial activity. Therefore, this study focused on 
the 5% permethrin cream used in Whitehall et al. (2013) looking 
for an antibacterial effect in its components. Initially, permethrin 
itself was the sole focus but after failing to identify substantial 
antibacterial effect with permethrin alone, formaldehyde (used as 
a preservative in the 5% permethrin cream) was investigated. As 
a result, it was identified that formaldehyde both alone and in the 
presence of permethrin can inhibit the growth of S. aureus and 
was, therefore, the most likely cause of the antibacterial activity 
in Whitehall et al. (2013). This article highlights the potential for 
the already used permethrin cream with a formaldehyde preserva-
tive as a treatment for antibiotic-resistant bacterial skin infections, 
particularly refractory impetigo.
2  | MATERIAL S AND METHODS
2.1 | Bacterial isolates and growth conditions
A total of ten strains of S. aureus including five methicillin-sus-
ceptible	 (MSSA	 1,	MSSA	 2,	MSSA	 4,	MSSA	 6	 and	MSSA	 8)	 and	
five	 methicillin-resistant	 (MRSA	 1,	 MRSA	 2,	 MRSA	 8,	 MRSA	
9 and MRSA 13; Table 1; Turnidge, Coombs, Daley, & Nimmo, 
2016) were obtained from Prof Iain Gosbell (Liverpool Hospital) 
and used throughout the experiments. Before use, each strain 
was freshly streaked on lysogeny broth (LB) agar plates (Difco 
Laboratories) and incubated overnight at 35 ± 2°C in a Binder 
Drying and Heating Chamber Model ED 115. After overnight in-
cubation, 2–3 colonies were suspended in Mueller-Hinton Broth 
(MHB) (Difco Laboratories) to OD595	0.09	(≈1	×	10
8 CFU/ml match-
ing a 0.5 McFarland turbidity standard) using a spectrophotometer 
(SPECTROstar Nano; BMG Labtech). These cells were then diluted 
to	1	×	107 CFU/ml, and appropriate volumes were used to have 
0.5	×	105 CFU/ml in the experiments.
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2.2 | In vitro antimicrobial testing
To identify the effect of permethrin and formaldehyde on the growth 
of S. aureus both alone and in combination, each strain was exposed 
to four concentrations of permethrin, four concentrations of for-
maldehyde and a combination of permethrin and formaldehyde. The 
four concentrations of permethrin and formaldehyde used were 
twofold concentrations and included the concentration present in 
the commercial permethrin cream. For the combination treatment, 
the concentration of permethrin and formaldehyde as present in the 
commercial permethrin cream was used.
Permethrin was obtained from Sigma, and its stock was made 
in MHB by dissolving in an ultrasonic cleaner (Scientifix) at 37°C 
for 10 min or until the solution was homogenous. Organic solvents 
like DMSO and methanol were not used for dissolving permethrin 
because they interfered with the growth of the test organisms. 
The bacterial inoculum, as prepared above, was added to each of 
1.25%, 2.5%, 5%, and 10% permethrin set in a 96-well microplate. 
Also, positive growth control of cells in MHB without permethrin 
was included. The cells were incubated on a benchtop orbital shaker 
(Thermo Scientific) for 20 hr at 35°C and 100 rpm. Each experiment 
was repeated three times independently and viable counts deter-
mined by a drop plate method as described in Section 2.4.
Formaldehyde solution was obtained from Electron Microscopy 
Sciences and diluted in MHB to make a stock. The bacterial inoculum 
was added to each of 0.07%, 0.15%, 0.3%, and 0.6% formaldehyde, 
and the experiment was conducted as was done for permethrin de-
scribed above.
To identify whether permethrin and formaldehyde affected each 
other's activity when present together, combination exposure ex-
periments were conducted in which each strain was tested in the 
presence of a combination of permethrin and formaldehyde at the 
concentrations found in the permethrin cream. The bacterial inoc-
ulum was added to each of 5% permethrin, 0.3% formaldehyde and 
both 5% permethrin and 0.3% formaldehyde together, and the exper-
iment was conducted as was done for permethrin described above.
2.3 | Time-kill assay
To determine the time at which formaldehyde exerts its antibacterial 
effect on S. aureus, whether permethrin delays bacterial growth and 
whether permethrin interferes with the effect that formaldehyde 
exerts against S. aureus, a time-kill assay was conducted. The bac-
terial inoculum was set up as was done for the combined exposure 
experiment described above and samples incubated on a benchtop 
orbital	 shaker	 at	 35°C	 and	100	 rpm.	At	 0,	 4,	 8,	 and	24	hr	 postin-
cubation, samples were taken and viable counts determined as de-
scribed in Section 2.4. Each experiment was repeated three times 
independently.
2.4 | Viable counts
Viable counts were determined using a drop plate method (modi-
fied	from	Miles,	Misra,	and	Irwin	(1938)).	Each	cell	suspension	was	
serially diluted tenfold and the appropriate dilutions dispensed onto 
LB agar plates in triplicate. The plates were incubated overnight 
(19–20 hr) in an incubator at 35°C. After incubation, the number of 
colonies was counted to determine the average CFU/ml and percent 
inhibition. Bactericidal activity was defined as a decrease in growth 
of	≥99.9%	(≥3log10	CFU/ml	reduction).
2.5 | Scanning electron microscopy
To visualize any effect that permethrin had on the growth and mor-
phology of S. aureus cells, each strain was grown in the presence 
TA B L E  1   Characteristics of methicillin-resistant strains of Staphylococcus aureus used in the experiments (Turnidge et al., 2016)
Strain Name Type (HA/CA)a  Origin Resistance pattern PVLb 
MRSA 1 QLD1 CA-MRSA Australia Typically no additional resistances (susceptible to non-β-
lactam classes of antimicrobial)
+










MRSA 9 SWP CA-MRSA New Zealand Typically no additional resistances +




aHealthcare Associated/Community Associated. 
bPanton Valentine Leucocidin production. 
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of 5% permethrin, fixed, and dehydrated for imaging by scanning 
electron microscopy (SEM). Cells were first grown either in the pres-
ence of 5% permethrin or in MHB alone as a positive growth control 
and incubated on a benchtop orbital shaker for 20 hr at 35°C and 
100 rpm. The cell suspension was then washed three times in 0.1 M 
sodium phosphate buffer (pH 7.4) (made by adding 0.1 M NaH2PO4 
[VWR Chemicals] to 0.1 M Na2HPO4 [Merck]). Washed cells were 
then resuspended in 2.5% glutaraldehyde (ProSciTech) in 0.1 M so-
dium phosphate buffer and incubated overnight at 4°C to fix the 
cells. Following overnight incubation at 4°C, the cells were again 
washed three times in 0.1 M sodium phosphate buffer before being 
dehydrated in graded ethanol (Chem-Supply) series (30%, 50%, 70%, 
80%,	90%	10	min	each	and	100%	for	one	hour).	The	cell	suspension	
was then transferred to a silica wafer for imaging by SEM.
Cells were examined by SEM using a Zeiss Merlin FE-SEM under 
low vacuum with a beam strength of 1 kV, an aperture of 30 µm, 
and with a working distance of 5 mm. A high-efficiency secondary 
electron (HE-SE2) detector was used to image cells.
3  | RESULTS
The effect of permethrin on the growth of S. aureus cells was tested 
at four concentrations to determine if the concentration of perme-
thrin found in a commonly used permethrin cream was capable of 
inhibiting bacterial growth. The focus was not on the determination 
of minimum inhibitory concentration (MIC) of permethrin but rather 
on the concentration found in the permethrin cream. The results of 
these experiments are summarized in Figure 1 as an average percent 
inhibition of three independent runs. 1.25% permethrin showed in-
hibition ranging from 0% to 34%, 2.5% permethrin showed inhibition 
ranging from 0% to 23%, 5% permethrin showed inhibition ranging 
from 0% to 32%, and 10% permethrin showed inhibition ranging 
from 0% to 32%. In several cases, no inhibition was observed as was 
an increase in cells in the permethrin-treated samples when com-
pared to the positive growth control. The observed inhibition was 
also not concentration-dependent. Poor aqueous solubility and una-
voidable use of multiple batches of permethrin across experiments 
could have been responsible for large variations seen in percent inhi-
bition in repeats of experiments but none of them was high enough 
to warrant bactericidal effects of permethrin.
The effect of formaldehyde on the growth of S. aureus cells was 
also tested at four concentrations to determine if the concentration 
of formaldehyde in a commonly used permethrin cream was capa-
ble of inhibiting bacterial growth. The results of these experiments 
are summarized in Figure 2 as an average percent inhibition of three 
independent runs. All four concentrations of formaldehyde (0.07%, 
0.15%, 0.3%, and 0.6%) were capable of inhibiting 100% of growth 
in all ten tested S. aureus strains.
The effect of 0.3% formaldehyde, 5% permethrin and a combi-
nation of 0.3% formaldehyde and 5% permethrin on the growth of 
S. aureus was investigated to determine the effect of permethrin in 
combination with formaldehyde (at the concentrations found in a 
commonly used permethrin cream) to inhibit bacterial growth. The 
results of these experiments are summarized in Figure 3 as average 
percent inhibition of three independent runs. Both 0.3% formalde-
hyde alone and in combination with 5% permethrin were capable of 
inhibiting 100% of growth in all ten tested S. aureus strains. 5% per-
methrin alone exhibited similar inhibition as seen in the permethrin 
experiments with inhibition ranging from 0% to 41%.
To identify the time at which formaldehyde and permethrin alone 
and in combination exert their activity against S. aureus, a time-kill 
assay was conducted on MSSA 1 and MRSA 1 in the presence of 
0.3% formaldehyde, 5% permethrin and a combination of 0.3% form-
aldehyde and 5% permethrin. In both experiments, 5% permethrin 
exposure resulted in growth rates similar to the positive growth con-
trol (Figure 4). However, 0.3% formaldehyde and the combination 
of 0.3% formaldehyde and 5% permethrin exhibited zero growth at 
all-time points including the zero-hour time point. This meant that on 
contact with formaldehyde, all bacterial cells were rendered nonvia-
ble with no latency in this activity.
After confirming that 5% permethrin exerts no significant effect 
on the growth of S. aureus in the above time-kill curve experiment, 
the remaining eight strains were only exposed to the combination 
of 0.3% formaldehyde and 5% permethrin. The results for the four 
methicillin-sensitive strains are summarized in Figure A1, and the 
F I G U R E  1   Average percent inhibition 
of methicillin-sensitive and methicillin-
resistant Staphylococcus aureus grown in 
1.25%, 2.5%, 5%, and 10% permethrin 
from three independent runs with 






















1.25% Permethrin 2.5% Permethrin 5% Permethrin 10% Permethrin
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results for the four methicillin-resistant strains are summarized in 
Figure A2. All eight strains exhibited zero growth in the combination 
treatment at all-time points.
All ten strains were grown in the presence of MHB alone and 
permethrin to compare and identify any changes to their morphol-
ogy as a result of permethrin exposure. The methicillin-sensitive 
strains can be seen in Figure 5, and the methicillin-resistant strains 
can be seen in Figure 6. As can be seen in these representative SEM 
images, there was no difference in the morphology between the 
untreated and permethrin-treated cells. There were also no obvious 
signs of forced cell death, cell shrinkage, lysis, or other forms of cell 
damage in the permethrin-treated cells. Furthermore, there appear 
to be cells that are embedded within the permethrin itself and capa-
ble of growth.
4  | DISCUSSION
In an earlier study, the use of a 5% permethrin cream in patients with 
scabies and impetigo was associated with a decrease in infection with 
antibiotic-resistant S. aureus (Whitehall et al., 2013). Permethrin is an 
insecticide used to treat scabies infections (Currie & McCarthy, 2010) 
and while its insecticidal effects are well characterized, the literature 
does not contain any mention of permethrin possessing direct anti-
bacterial properties. There is however some evidence that it can af-
fect the composition of bacterial populations (Dada et al., 2019; Jin, 
Wu, Zeng, & Fu, 2017). This study, therefore, attempted to identify 
what component of the permethrin cream was responsible for the 
observed antibacterial effect and found that while permethrin itself 
does not possess antibacterial activity; the formaldehyde preserva-
tive was more than sufficient for the killing of S. aureus.
In this study, it was observed that none of the tested concen-
trations of permethrin was able to significantly inhibit the growth 
of S. aureus for it to be termed as antibacterial. None of the tested 
concentrations exhibited more than 41% inhibition. As this is well 
below	the	≥99.9%	inhibition	required	for	it	to	be	termed	bactericidal,	
permethrin itself was not responsible for the observed antibacterial 
effect in Whitehall et al. (2013). However, the permethrin cream used 
in Whitehall et al. (2013) contained 0.3% formaldehyde as a preser-
vative. Formaldehyde is known to possess strong antibacterial prop-
erties (with a MIC of 156 mg/L [0.02%] against S. aureus) and is hence 
used as a preservative (Mazzola, Jozala, Novaes, Moriel, & Penna, 
2009). Formaldehyde may, therefore, have been responsible for the 
observed antibacterial activity. This is supported by all four tested 
concentrations of formaldehyde completely inhibiting the growth of 
all ten S. aureus strains as well as 0.3% formaldehyde being able to 
F I G U R E  2   Average percent inhibition 
of methicillin-sensitive and methicillin-
resistant Staphylococcus aureus grown 
in 0.07%, 0.15%, 0.3%, and 0.6% 
formaldehyde from three independent 























0.07% Formaldehyde 0.15% Formaldehyde 0.3% Formaldehyde 0.6% Formaldehyde
F I G U R E  3   Average percent inhibition 
of methicillin-sensitive and methicillin-
resistant Staphylococcus aureus grown in 
0.3% formaldehyde and 5% permethrin 
alone, and combined from three 
independent runs with standard deviation 
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completely inhibit bacterial growth even in the presence of perme-
thrin. This indicates that permethrin does not interfere with the anti-
bacterial action of formaldehyde. The conducted time-kill assay was 
able to confirm that the rate of growth of S. aureus was unaffected 
by permethrin as well as that formaldehyde both alone and in combi-
nation with permethrin exhibits complete inhibition of S. aureus very 
rapidly with no growth seen even at the 0-hr time point.
While the above results indicate that permethrin has no bacte-
ricidal effect, it may have the ability to alter the growth of S. aureus 
cells in some other way. However, as can be seen in the representa-
tive electron micrographs, both the control and permethrin-treated 
cells exhibit similar morphology with no indication of cell damage. 
Furthermore, healthy S. aureus cells embedded within the perme-
thrin imply that S. aureus is unaffected by exposure to permethrin.
F I G U R E  4   Time-kill curves of 
methicillin-sensitive and methicillin-
resistant Staphylococcus aureus grown in 
0.3% formaldehyde and 5% permethrin 
alone, and combined from three 
independent runs with standard deviation 





































0.3% Formaldehyde 0.3% Formaldehyde + 5% Permethrin
(b)
(a)
F I G U R E  5   Scanning electron micrographs of methicillin-sensitive Staphylococcus aureus grown in Mueller-Hinton broth or permethrin. 
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Through combination exposure and time-kill assays, this study 
has shown that 5% permethrin does not possess strong bacteri-
cidal properties, nor does it act antagonistically against the action 
of formaldehyde. Therefore, the observed antibacterial activity in 
the earlier study (Whitehall et al., 2013) was most likely due to the 
presence of 0.3% formaldehyde in the 5% permethrin cream. While 
the results presented here show that permethrin cannot be used as 
a novel antimicrobial, they do bring to attention the potential for an-
tibacterial treatment using formaldehyde at low concentrations in 
medicinal creams.
Formaldehyde is widely used in cosmetics and medicines but its 
risks need to be investigated further than what is currently available. 
While the airborne formaldehyde gas is known to cause nasopharyn-
geal cancer (Nielsen, Larsen, & Wolkoff, 2017) and allergic contact 
dermatitis (De Groot, Flyvholm, Lensen, Menné, & Coenraads, 2009), 
and its effects in allergic individuals are well characterized (Hauksson 
et al., 2016), the effects of dermally applied formaldehyde in nonal-
lergic individuals are not as well understood (most studies published 
in	the	1980s).	Similarly,	the	rate	of	formaldehyde	absorption	through	
human skin is unknown with no in vivo human studies available. Only 
animal studies and studies on excised human skin, published in the 
1980s,	 indicate	 that	 dermal	 application	 of	 low	 concentrations	 of	
formaldehyde results in minimal absorption through unbroken skin 
(Bartnik,	 Gloxhuber,	 &	 Zimmermann,	 1985;	 Iversen,	 1986;	 Lodén,	
1986).	 A	more	 recent	 study	 showed	 that	 2%	 formaldehyde	 caused	
swelling in mice ears but the minimal concentration required for this 
effect was not identified (Saito et al., 2011). Widespread use of form-
aldehyde in cosmetics and medicinal creams may highlight its relative 
safety in the dermal application at low concentrations.
It is, therefore, possible that a formaldehyde cream could serve 
as a last-resort treatment in infections with antibiotic-resistant bac-
teria that are not responsive to any other form of therapy. A benefit 
of using formaldehyde in this manner is that it is difficult for bacte-
ria to develop resistance to it. No Gram-positive bacteria have been 
reported to be resistant to formaldehyde and while bacteria, such 
as Amycolatopsis methanolica and Mycobacterium gastri, are tolerant 
to formaldehyde, both are still susceptible at concentrations above 
0.8	mM	(Bystrykh	et	al.,	1993).
The results presented here, combined with the potent antibac-
terial activity of formaldehyde, the difficulty bacteria have in de-
veloping adequate resistance to formaldehyde and the implication 
that low concentrations of formaldehyde may be safe for use in 
humans, highlight that formaldehyde-containing cream such as a 
permethrin cream can be used for treating refractory infections 
(Nikolic, Mudgil, & Whitehall, 2019). By treating infections with 
multi-resistant strains of S. aureus, formaldehyde could help to 
combat antibiotic resistance by both curing what may be consid-
ered incurable infections and reducing the use of antibiotics. For 
example, in scabies infections, a permethrin cream with a formal-
dehyde preservative would be sufficient in treating both scabies 
and the associated bacterial infections, rather than using perme-
thrin cream for scabies and a separate antibiotic for the bacterial 
infections.
While permethrin creams containing formaldehyde are already 
medically approved for dermal application, it is recommended that 
more research is conducted to confirm what was published in the 
80s	 and	 to	 fill	 the	 current	 gaps	 present	 in	 the	 literature	 before	
using it for treating antibiotic-resistant bacterial skin infections. 
This would include research into how formaldehyde affects hu-
mans after dermal application, the rate of absorption through 
human skin and whether or not dermally applied formaldehyde 
can release dangerous levels of airborne formaldehyde. However, 
the currently available information does indicate that the dermal 
application of low concentrations of formaldehyde is unlikely to 
cause significant harm.
5  | CONCLUSION
The results presented here conclude that permethrin does 
not possess strong antibacterial properties and that formalde-
hyde was responsible for the observed antibacterial effect after 
F I G U R E  6   Scanning electron micrographs of methicillin-resistant Staphylococcus aureus grown in Mueller Hinton broth or permethrin. 
The top row shows control cells, and the bottom row shows cells treated with 5% permethrin. (a & f) MRSA 1; (b & g) MRSA 2; (c & h) MRSA 
8;	(d	&	i)	MRSA	9;	and	(e	&	j)	MRSA	13
(a)
(f) (g) (h) (i) (j)
(b) (c) (d) (e)
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administration of a 5% permethrin cream. Formaldehyde is a 
known antiseptic, and it could serve as a last resort in bacterial in-
fections with no other treatment option. However, the risks asso-
ciated with its use would need to be considered and, in the case of 
dermal contact in nonallergic individuals, investigated further. The 
continued use of formaldehyde in dermal creams suggests lower 
risk than currently thought.
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APPENDIX 
F I G U R E  A 1   Time-kill curves of 
methicillin-sensitive Staphylococcus 
aureus grown in 0.3% formaldehyde and 
5% permethrin combined from three 
independent runs with standard deviation 











































































0.3% Formaldehyde + 5% Permethrin
F I G U R E  A 2   Time-kill curves of 
methicillin-resistant Staphylococcus 
aureus grown in 0.3% formaldehyde and 
5% permethrin combined from three 
independent runs with standard deviation 
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